PER-076-03已完成未知
RANDOMIZED STUDY OF PHASE III WITH RADIOTHERAPY IN PATIENTS MASTECTOMIZED BY BREAST CANCER OF CLINICAL STAGE II, WITH ONE TO THREE POSITIVE GANGLES
EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),0 个研究点目标入组 0 人开始时间: 2004年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients should be women with breast adenocarcinoma,
- •histologically confirmed, with a primary tumor of <5 cm and 1-3 positive axillary lymph nodes. Patients with positive lymph nodes only by cytokeratin staining and negative with hematoxylin-eosin are not eligible.
- •Patients must not have received Trastuzumab previously.
排除标准
- •pregnant women
研究者
相似试验
进行中（未招募）
1 期
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma. - CodeletedEUCTR2008-007295-14-ATEORTC488
进行中（未招募）
不适用
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma. - CodeletedEUCTR2008-007295-14-GBEORTC488
进行中（未招募）
1 期
Phase III intergroup Study of Radiotherapy versus TemozolomideAlone versus Radiotherapy with concomitant and adjuvantTemozolomide for Patients with 1p/19q Codeleted AnaplasticGlioma.ewly Diagnosed Anaplastic Glioma with Chromosomal co-deletions of 1p and 19qMedDRA version: 19.0Level: PTClassification code 10002224Term: Anaplastic astrocytomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10027744Term: Mixed astrocytoma-oligodendrogliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10065443Term: Malignant gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10026659Term: Malignant oligodendrogliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-007295-14-NLEuropean Organization for Research and Treatment of Cancer (EORTC)488
已完成
3 期
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma.anaplastic oligodendroglial tumors10029211NL-OMON44004European Organisation for Research in Treatment of Cancer (EORTC)54
进行中（未招募）
1 期
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma. - Codeletedewly Diagnosed Anaplastic Glioma with Chromosomal co-deletions of 1p and 19qMedDRA version: 12.1Level: LLTClassification code 10065443Term: Malignant gliomaMedDRA version: 12.1Level: LLTClassification code 10026659Term: Malignant oligodendrogliomaMedDRA version: 12.1Level: LLTClassification code 10002224Term: Anaplastic astrocytomaMedDRA version: 12.1Level: LLTClassification code 10027744Term: Mixed astrocytoma-oligodendrogliomaEUCTR2008-007295-14-BEEORTC488